http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107868770-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-182 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y406-01002 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 |
| filingDate | 2017-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107868770-B |
| titleOfInvention | Construction and application of antifungal and oomycete active substance HSAF high-producing strain based on c-di-GMP synthesis related gene |
| abstract | The invention discloses application of c-di-GMP synthesis related genes in constructing high-yield strains of antifungal and oomycete active substances HSAF, and a construction method of high-yield engineering strains of antifungal and oomycete active substances HSAF, namely, 10 c-di-GMP synthesis related genes in an original strain are knocked out, and no marker gene is introduced. The capability of the engineering strain for producing the active substance HSAF of the antifungal and the oomycetes is 3 times that of the wild type, and the engineering strain lays a foundation for the industrialized fermentation of the HSAF. |
| priorityDate | 2017-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 118.